⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STOK News
Stoke Therapeutics, Inc. Common Stock
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
businesswire.com
STOK
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
businesswire.com
STOK
BIIB
Form 8-K
sec.gov
STOK
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
Form 8-K
sec.gov
STOK
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
businesswire.com
STOK
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
Form 8-K
sec.gov
STOK
BIIB